NetApp, Inc.

NTAP

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: Eventide/NetApp (NTAP)** This position is outside Eventide's typical biotech focus—NetApp is a data infrastructure/storage software company with no direct drug development exposure.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 3,937Value: $427K

**Signal Note: Eventide/NetApp (NTAP)** This position is outside Eventide's typical biotech focus—NetApp is a data infrastructure/storage software company with no direct drug development exposure. The $427K position likely reflects Eventide's conviction in NetApp's enterprise AI/ML infrastructure tailwinds rather than values-based biotech criteria, suggesting a portfolio diversification play into secular cloud computing demand.

More NTAP Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund LLY1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: